Back to Results
First PageMeta Content
Biotechnology / Healthcare in Australia / Bristol-Myers Squibb / Cetuximab / KRAS / Panitumumab / Colorectal cancer / Biomarker / Pharmaceutical Benefits Scheme / Medicine / Biology / Health


Public Summary Document Application No[removed]KRAS mutation testing for panitumumab Sponsor/Applicant/s: Amgen Australia
Add to Reading List

Document Date: 2014-11-06 23:51:26

Open Document

File Size: 58,65 KB

Share Result on Facebook

Company

MSAC / Amgen Australia / /

Currency

USD / /

IndustryTerm

health services / agreed clinical protocols / health technology assessments / /

MedicalCondition

colorectal cancer / responsive tumours / tumour / metastatic colorectal cancer / /

MedicalTreatment

chemotherapy / clinical protocols / /

Organization

Australian Health Ministers’ Advisory Council / National Association of Testing Authorities / Medicare / /

Position

consultant physician / Governor / Minister / Executive / /

Technology

agreed clinical protocols / chemotherapy / /

URL

www.msac.gov.au / /

SocialTag